ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSE GONZALEZ

Geriatric Medicine

42,861

$752K

2203
2045 are 65+

1%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$18
Average prescription price

Avg: $59

MARC GOLDSTEIN D.O.C.M.D.

Geriatric Medicine

37,887

$2.66M

1087
970 are 65+

8%
patients receiving schedule two controlled substances

Avg: 11%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $59

ALAN ROSENZWEIG DO

Geriatric Medicine

23,343

$1.33M

638
536 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $59

CHENG-AN MAO M.D.

Geriatric Medicine

21,697

$1.56M

535
458 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $59

GAMIL MAKAR M.D

Geriatric Medicine

18,554

$1.55M

415
338 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $59

HARVEY GROSS M.D.

Geriatric Medicine

16,263

$896K

600
572 are 65+

12%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $59

JAMES WOO M.D.

Geriatric Medicine

12,731

$783K

418
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $59

STEVEN EISENSTAT D.O

Geriatric Medicine

10,874

$918K

675
616 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $59

RITU SURI MD

Geriatric Medicine

10,653

$623K

328
317 are 65+

12%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$58
Average prescription price

Avg: $59

MICHAEL GIULIANO D.O.

Geriatric Medicine

9,785

$756K

505
434 are 65+

9%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $59

JILL MORTENSEN D.O.

Geriatric Medicine

9,378

$544K

646
461 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$58
Average prescription price

Avg: $59

SESHADRI CHAKRAVARTHI MD

Geriatric Medicine

9,202

$397K

278
260 are 65+

26%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$43
Average prescription price

Avg: $59

MILDRED SABO MD

Geriatric Medicine

9,138

$477K

289
268 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $59

PRITI GUJAR M.D

Geriatric Medicine

8,958

$528K

234
231 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $59

HOWARD SCHOENFELD D.O.

Geriatric Medicine

8,687

$452K

235
225 are 65+

19%
patients receiving schedule two controlled substances

Avg: 11%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $59

LORI REAVES DO

Geriatric Medicine

8,264

$574K

687
558 are 65+

16%
patients receiving schedule two controlled substances

Avg: 11%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $59

BENJAMIN LESSIG D.O.

Geriatric Medicine

7,458

$627K

263
243 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $59

ROBERT CHEN M.D.

Geriatric Medicine

6,665

$354K

291
260 are 65+

16%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $59

LARISA GOLUB MD

Geriatric Medicine

6,572

$398K

206
199 are 65+

32%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $59

STEFANOS PANTAGIS MD

Geriatric Medicine

6,008

$386K

318
272 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $59

RAJANKUMAR PATEL M.D.

Geriatric Medicine

5,715

$344K

294
238 are 65+

12%
patients receiving schedule two controlled substances

Avg: 11%

6%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $59

JOSHUA RAYMOND MD

Geriatric Medicine

4,655

$313K

205
179 are 65+

14%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $59

MARCIANO FIGUEROA M.D.

Geriatric Medicine

4,505

$222K

233
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $59

MANETTE FINE D.O.

Geriatric Medicine

3,603

$204K

117
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $59

FRED KOBYLARZ MD, MPH

Geriatric Medicine

3,034

$228K

213
184 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank